| # | Drug | Count |
|---|---|---|
| 0 | OLAPARIB | 23 |
| 1 | CARBOPLATIN | 17 |
| 2 | DOCETAXEL | 17 |
| 3 | DOCETAXEL ANHYDROUS | 17 |
| 4 | ENZALUTAMIDE | 13 |
| 5 | ABIRATERONE ACETATE | 12 |
| 6 | BEVACIZUMAB | 12 |
| 7 | LETROZOLE | 12 |
| 8 | LEUPROLIDE ACETATE | 12 |
| 9 | PREDNISOLONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABAZITAXEL | 11 | 0.0031 |
| 1 | FROVATRIPTAN SUCCINATE | 1 | 0.0013 |
| 2 | OLAPARIB | 23 | 0.0011 |
| 3 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 4 | TALAZOPARIB | 1 | 0.0005 |
| 5 | GOSERELIN | 7 | 0.0005 |
| 6 | PLECANATIDE | 1 | 0.0005 |
| 7 | PRASTERONE | 1 | 0.0004 |
| 8 | FULVESTRANT | 11 | 0.0003 |
| 9 | ABIRATERONE ACETATE | 12 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 25 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 23 |
| 2 | Platinum-based Drug [EPC] | 19 |
| 3 | Androgen Receptor Inhibitor [EPC] | 16 |
| 4 | Aromatase Inhibitor [EPC] | 16 |
| 5 | Corticosteroid [EPC] | 14 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 12 |
| 7 | Estrogen Receptor Antagonist [EPC] | 11 |
| 8 | RANK Ligand Inhibitor [EPC] | 11 |
| 9 | Kinase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 23 | 0.0011 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Estrogen Receptor Antagonist [EPC] | 11 | 0.0003 |
| 3 | Androgen Receptor Inhibitor [EPC] | 16 | 0.0002 |
| 4 | Microtubule Inhibitor [EPC] | 25 | 0.0002 |
| 5 | Aromatase Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 19 | 0.0001 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 12 | 0.0001 |